Syros Pharmaceuticals Inc (SYRS)
5.13
-0.08
(-1.54%)
USD |
NASDAQ |
May 03, 16:00
5.13
0.00 (0.00%)
After-Hours: 18:36
Syros Pharmaceuticals Market Cap: 135.71M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 137.82M |
| May 01, 2024 | 143.91M |
| April 30, 2024 | 142.85M |
| April 29, 2024 | 142.32M |
| April 26, 2024 | 133.33M |
| April 25, 2024 | 134.91M |
| April 24, 2024 | 134.12M |
| April 23, 2024 | 135.97M |
| April 22, 2024 | 132.00M |
| April 19, 2024 | 120.10M |
| April 18, 2024 | 124.86M |
| April 17, 2024 | 135.18M |
| April 16, 2024 | 147.08M |
| April 15, 2024 | 141.53M |
| April 12, 2024 | 142.59M |
| April 11, 2024 | 156.61M |
| April 10, 2024 | 146.29M |
| April 09, 2024 | 145.50M |
| April 08, 2024 | 119.04M |
| April 05, 2024 | 123.54M |
| April 04, 2024 | 127.51M |
| April 03, 2024 | 131.74M |
| April 02, 2024 | 122.61M |
| April 01, 2024 | 133.33M |
| March 28, 2024 | 141.53M |
| Date | Value |
|---|---|
| March 27, 2024 | 154.49M |
| March 26, 2024 | 165.34M |
| March 25, 2024 | 169.30M |
| March 22, 2024 | 165.87M |
| March 21, 2024 | 167.72M |
| March 20, 2024 | 167.45M |
| March 19, 2024 | 164.81M |
| March 18, 2024 | 161.37M |
| March 15, 2024 | 158.99M |
| March 14, 2024 | 159.52M |
| March 13, 2024 | 171.16M |
| March 12, 2024 | 170.89M |
| March 11, 2024 | 173.54M |
| March 08, 2024 | 179.09M |
| March 07, 2024 | 183.33M |
| March 06, 2024 | 188.62M |
| March 05, 2024 | 189.11M |
| March 04, 2024 | 201.01M |
| March 01, 2024 | 204.98M |
| February 29, 2024 | 192.02M |
| February 28, 2024 | 190.17M |
| February 27, 2024 | 194.13M |
| February 26, 2024 | 198.10M |
| February 23, 2024 | 192.02M |
| February 22, 2024 | 187.52M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.64M
Minimum
Sep 07 2022
840.15M
Maximum
Jan 19 2021
245.74M
Average
222.39M
Median
Nov 07 2019
Market Cap Benchmarks
| PDS Biotechnology Corp | 140.30M |
| PAVmed Inc | 19.26M |
| Moderna Inc | 47.85B |
| Altimmune Inc | 518.24M |
| iBio Inc | 6.829M |
Market Cap Related Metrics
| PS Ratio | 14.63 |
| Price to Book Value | 8.145 |
| Price | 5.13 |
| Earnings Yield | -113.1% |